ID   S6A19_RAT               Reviewed;         634 AA.
AC   Q2A865; A4ZVM8;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 2.
DT   02-OCT-2024, entry version 112.
DE   RecName: Full=Sodium-dependent neutral amino acid transporter B(0)AT1;
DE   AltName: Full=Solute carrier family 6 member 19;
DE   AltName: Full=System B(0) neutral amino acid transporter AT1;
GN   Name=Slc6a19 {ECO:0000312|RGD:1594328};
GN   Synonyms=B0at1 {ECO:0000312|EMBL:CAI64591.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000312|EMBL:CAI64591.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney {ECO:0000312|EMBL:CAI64591.1};
RA   Volk C., Koepsell H., Arndt P.;
RT   "Cloning and characterization of the rat B0 amino acid transporter 1.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar Kyoto;
RX   PubMed=17646927; DOI=10.1007/s11010-007-9548-9;
RA   Pinho M.J., Serrao M.P., Jose P.A., Soares-da-Silva P.;
RT   "Organ specific underexpression renal of Na+-dependent B0AT1 in the SHR
RT   correlates positively with overexpression of NHE3 and salt intake.";
RL   Mol. Cell. Biochem. 306:9-18(2007).
RN   [3] {ECO:0000305}
RP   INDUCTION BY HIGH SALT INTAKE.
RX   PubMed=17264310; DOI=10.1152/ajprenal.00465.2006;
RA   Pinho M.J., Serrao M.P., Soares-da-Silva P.;
RT   "High-salt intake and the renal expression of amino acid transporters in
RT   spontaneously hypertensive rats.";
RL   Am. J. Physiol. 292:F1452-F1463(2007).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transporter that mediates resorption of neutral amino acids
CC       across the apical membrane of renal and intestinal epithelial cells.
CC       This uptake is sodium-dependent and chloride-independent. Requires
CC       CLTRN in kidney or ACE2 in intestine for cell surface expression and
CC       amino acid transporter activity. {ECO:0000250|UniProtKB:Q9D687}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-alanine(in) + Na(+)(in) = L-alanine(out) + Na(+)(out);
CC         Xref=Rhea:RHEA:29283, ChEBI:CHEBI:29101, ChEBI:CHEBI:57972;
CC         Evidence={ECO:0000250|UniProtKB:Q695T7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-cysteine(in) + Na(+)(in) = L-cysteine(out) + Na(+)(out);
CC         Xref=Rhea:RHEA:68232, ChEBI:CHEBI:29101, ChEBI:CHEBI:35235;
CC         Evidence={ECO:0000250|UniProtKB:Q695T7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-glutamine(in) + Na(+)(in) = L-glutamine(out) + Na(+)(out);
CC         Xref=Rhea:RHEA:68236, ChEBI:CHEBI:29101, ChEBI:CHEBI:58359;
CC         Evidence={ECO:0000250|UniProtKB:Q695T7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycine(in) + Na(+)(in) = glycine(out) + Na(+)(out);
CC         Xref=Rhea:RHEA:68228, ChEBI:CHEBI:29101, ChEBI:CHEBI:57305;
CC         Evidence={ECO:0000250|UniProtKB:Q695T7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-isoleucine(in) + Na(+)(in) = L-isoleucine(out) + Na(+)(out);
CC         Xref=Rhea:RHEA:29275, ChEBI:CHEBI:29101, ChEBI:CHEBI:58045;
CC         Evidence={ECO:0000250|UniProtKB:Q695T7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-leucine(in) + Na(+)(in) = L-leucine(out) + Na(+)(out);
CC         Xref=Rhea:RHEA:29263, ChEBI:CHEBI:29101, ChEBI:CHEBI:57427;
CC         Evidence={ECO:0000250|UniProtKB:Q695T7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-methionine(in) + Na(+)(in) = L-methionine(out) + Na(+)(out);
CC         Xref=Rhea:RHEA:68240, ChEBI:CHEBI:29101, ChEBI:CHEBI:57844;
CC         Evidence={ECO:0000250|UniProtKB:Q695T7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-phenylalanine(in) + Na(+)(in) = L-phenylalanine(out) +
CC         Na(+)(out); Xref=Rhea:RHEA:68244, ChEBI:CHEBI:29101,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000250|UniProtKB:Q695T7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-serine(in) + Na(+)(in) = L-serine(out) + Na(+)(out);
CC         Xref=Rhea:RHEA:29575, ChEBI:CHEBI:29101, ChEBI:CHEBI:33384;
CC         Evidence={ECO:0000250|UniProtKB:Q695T7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-tryptophan(in) + Na(+)(in) = L-tryptophan(out) + Na(+)(out);
CC         Xref=Rhea:RHEA:68252, ChEBI:CHEBI:29101, ChEBI:CHEBI:57912;
CC         Evidence={ECO:0000250|UniProtKB:Q695T7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-tyrosine(in) + Na(+)(in) = L-tyrosine(out) + Na(+)(out);
CC         Xref=Rhea:RHEA:68248, ChEBI:CHEBI:29101, ChEBI:CHEBI:58315;
CC         Evidence={ECO:0000250|UniProtKB:Q695T7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-valine(in) + Na(+)(in) = L-valine(out) + Na(+)(out);
CC         Xref=Rhea:RHEA:29267, ChEBI:CHEBI:29101, ChEBI:CHEBI:57762;
CC         Evidence={ECO:0000250|UniProtKB:Q695T7};
CC   -!- SUBUNIT: Interacts in a tissue-specific manner with ACE2 in small
CC       intestine and with CLTRN in the kidney. Interacts with CLTRN; this
CC       interaction is required for trafficking of SLC6A19 to the plasma
CC       membrane and for its catalytic activation in kidneys. Interacts with
CC       ACE2; this interaction is required for trafficking of SLC6A19 to the
CC       plasma membrane and for its catalytic activation in intestine.
CC       Interacts with ANPEP; the interaction positively regulates its amino
CC       acid transporter activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q9D687}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q695T7}; Multi-
CC       pass membrane protein {ECO:0000255}.
CC   -!- INDUCTION: By high salt intake in SHR rats. Reduced level upon high
CC       salt intake in Wistar Kyoto rats. {ECO:0000269|PubMed:17264310}.
CC   -!- SIMILARITY: Belongs to the sodium:neurotransmitter symporter (SNF) (TC
CC       2.A.22) family. SLC6A19 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ890206; CAI64591.1; -; mRNA.
DR   EMBL; EF474455; ABP63542.1; -; mRNA.
DR   RefSeq; NP_001034811.1; NM_001039722.2.
DR   AlphaFoldDB; Q2A865; -.
DR   SMR; Q2A865; -.
DR   STRING; 10116.ENSRNOP00000028917; -.
DR   DrugCentral; Q2A865; -.
DR   GuidetoPHARMACOLOGY; 939; -.
DR   GlyCosmos; Q2A865; 5 sites, No reported glycans.
DR   GlyGen; Q2A865; 5 sites.
DR   iPTMnet; Q2A865; -.
DR   PhosphoSitePlus; Q2A865; -.
DR   PaxDb; 10116-ENSRNOP00000028917; -.
DR   Ensembl; ENSRNOT00000036714.4; ENSRNOP00000028917.2; ENSRNOG00000026501.6.
DR   Ensembl; ENSRNOT00055004683; ENSRNOP00055003454; ENSRNOG00055003012.
DR   Ensembl; ENSRNOT00060044233; ENSRNOP00060036678; ENSRNOG00060025538.
DR   Ensembl; ENSRNOT00065031065; ENSRNOP00065024736; ENSRNOG00065018495.
DR   GeneID; 664630; -.
DR   KEGG; rno:664630; -.
DR   UCSC; RGD:1594328; rat.
DR   AGR; RGD:1594328; -.
DR   CTD; 340024; -.
DR   RGD; 1594328; Slc6a19.
DR   eggNOG; KOG3659; Eukaryota.
DR   GeneTree; ENSGT00940000154896; -.
DR   HOGENOM; CLU_006855_7_2_1; -.
DR   InParanoid; Q2A865; -.
DR   OMA; WPKELIT; -.
DR   OrthoDB; 3084493at2759; -.
DR   PhylomeDB; Q2A865; -.
DR   TreeFam; TF343812; -.
DR   Reactome; R-RNO-352230; Amino acid transport across the plasma membrane.
DR   Reactome; R-RNO-442660; Na+/Cl- dependent neurotransmitter transporters.
DR   PRO; PR:Q2A865; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000026501; Expressed in jejunum and 8 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0031526; C:brush border membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0015175; F:neutral L-amino acid transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW.
DR   GO; GO:0003333; P:amino acid transmembrane transport; ISO:RGD.
DR   GO; GO:0015804; P:neutral amino acid transport; ISO:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IBA:GO_Central.
DR   InterPro; IPR000175; Na/ntran_symport.
DR   InterPro; IPR002438; Neutral_aa_SLC6.
DR   InterPro; IPR037272; SNS_sf.
DR   NCBIfam; NF037979; Na_transp; 1.
DR   PANTHER; PTHR11616:SF125; SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1; 1.
DR   PANTHER; PTHR11616; SODIUM/CHLORIDE DEPENDENT TRANSPORTER; 1.
DR   Pfam; PF00209; SNF; 1.
DR   PRINTS; PR00176; NANEUSMPORT.
DR   PRINTS; PR01206; ORPHTRNSPORT.
DR   SUPFAM; SSF161070; SNF-like; 1.
DR   PROSITE; PS00610; NA_NEUROTRAN_SYMP_1; 1.
DR   PROSITE; PS50267; NA_NEUROTRAN_SYMP_3; 1.
PE   1: Evidence at protein level;
KW   Amino-acid transport; Glycoprotein; Membrane; Phosphoprotein;
KW   Reference proteome; Symport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..634
FT                   /note="Sodium-dependent neutral amino acid transporter
FT                   B(0)AT1"
FT                   /id="PRO_0000299498"
FT   TOPO_DOM        1..41
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        42..62
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        63..65
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        66..86
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        87..119
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        120..140
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        141..192
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        193..213
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        214..221
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        222..242
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        243..268
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        269..289
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        290..304
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        305..325
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        326..413
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        414..434
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        435..456
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        457..477
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        478..490
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        491..511
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        512..531
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        532..552
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        553..581
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        582..602
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        603..634
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         627
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D687"
FT   CARBOHYD        158
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        182
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        258
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        354
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        368
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        32
FT                   /note="R -> K (in Ref. 1; CAI64591)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        186
FT                   /note="S -> P (in Ref. 1; CAI64591)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        276
FT                   /note="F -> Y (in Ref. 1; CAI64591)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        433
FT                   /note="F -> L (in Ref. 2; ABP63542)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        458
FT                   /note="L -> F (in Ref. 2; ABP63542)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   634 AA;  71232 MW;  005015BEAF876CE4 CRC64;
     MVRLVLPNPG LEDRIPSLDE LEVIEKEEAS SRPKWDNKAQ YMLTCVGFCV GLGNVWRFPY
     LCQSHGGGAF MIPFLILLVL EGIPLLHLEF AIGQRLRKGS VGVWSSIHPA LKGVGIASMF
     VSFMVGLYYN TIIAWVMWYF FNSFQEPLPW SECPLNQNQT GYVEECAKSS SVDYFWYRET
     LNISTSISDS GSIQWWILLC LTCAWSVLYV CTIRGIETTG KAVYITSTLP YVVLTIFLIR
     GLTLKGATNG IVFLFTPNIT ELSNPNTWLD AGAQVFYSFS LAFGGLISFS SYNSVHNNCE
     MDSVIVSIIN GFTSVYAATV VYSIIGFRAT ERFDDCVNTN ILTLINGFDL PEGNVTAENF
     EAYQHWCNAT NPEAYAQLTF QTCDINTFLS EGVEGTGLAF IVFTEAITKM PVSPLWSVLF
     FIMLFCLGLS SMFGNMEGVV VPLQDLNITP KKWPKELLTG LICLGTYLIA FIFTLNSGQY
     WLSLLDSYAG SIPLLIIAFC EMFAVVYVYG VDRFNKDIEF MIGHKPNIFW QVTWRVVSPL
     IMLVIFLFFF VIEVNKQLMY SVWDPDYEEF PKSQKVPYPD WVYAVVVIVA GVPCLTIPCF
     AIYKLIRNYC QKSGDQHGLV NALSTASVNG DLKN
//
